Current status of vaccines for parainfluenza virus infections

Pediatric Infectious Disease Journal

Volumn 27, Issue SUPPL. 10, 2008, Pages

  Sato, Masatoki ^a   Wright, Peter F ^a,b  

^a VANDERBILT UNIVERSITY   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Parainfluenza virus; Paramyxoviridae; Respiratory syncytial virus; Vaccine

Indexed keywords

PARAINFLUENZA VACCINE;

ADULT; CHILD; COLD; CROUP; GENETICS; HUMAN; IMMUNOLOGY; INFANT; MUTATION; PARAINFLUENZA VIRUS 1; PARAINFLUENZA VIRUS 2; PARAINFLUENZA VIRUS 3; PARAINFLUENZA VIRUS 4; REVIEW; RNA VIRUS INFECTION; VIROLOGY; VIRUS INFECTION;

ADULT; CHILD; COLD; CROUP; HUMANS; INFANT; MUTATION; PARAINFLUENZA VACCINES; PARAINFLUENZA VIRUS 1, HUMAN; PARAINFLUENZA VIRUS 2, HUMAN; PARAINFLUENZA VIRUS 3, BOVINE; PARAINFLUENZA VIRUS 3, HUMAN; PARAINFLUENZA VIRUS 4, HUMAN; RESPIROVIRUS INFECTIONS; RUBULAVIRUS INFECTIONS;

EID: 56149084169     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e318168b76f     Document Type: Conference Paper

References (16)

1. Parrott RH, Vargosko AJ, Kim HW, Bell JA, Chanock RM. Acute respiratory diseases of viral etiology. III. Parainfluenza. Myxoviruses. Am J Public Health Nations Health. 1962;52:907-917.
2. Reed G, Jewett PH, Thompson J, Tollefson S, Wright PF. Epidemiology and clinical impact of parainfluenza virus infections in otherwise healthy infants and young children <5 years old. J Infect Dis. 1997;175:807-813. (Pubitemid 27142952)
3. Henrickson KJ, Hoover S, Kehl KS, Hua W. National disease burden of respiratory viruses detected in children by polymerase chain reaction. Pediatr Infect Dis J. 2004;23:S11-S18. (Pubitemid 38168906)
4. Smith CB, Purcell RH, Bellanti JA, Chanock RM. Protective effect of antibody to parainfluenza type 1 virus. N Engl J Med. 1966;275:1145-1152.
5. Kim HW, Canchola JG, Brandt CD, et al. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am J Epidemiol. 1969;89:422-434.
6. Jacobs AA, Theelen RP, Jaspers R, et al. Protection of dogs for 13 months against Bordetella bronchiseptica and canine parainfluenza virus with a modified live vaccine. Vet Rec. 2005;157:19-23. (Pubitemid 40975671)
7. Karron RA, Wright PF, Hall SL, et al. A live attenuated bovine parainfluenza virus type 3 vaccine is safe, infectious, immunogenic, and phenotypically stable in infants and children. J Infect Dis. 1995;171: 1107-1114.
8. Greenberg DP, Walker RE, Lee MS, et al. A bovine parainfluenza virus type 3 vaccine is safe and immunogenic in early infancy. J Infect Dis. 2005;191:1116-1122. (Pubitemid 40404370)
9. Belshe RB, Newman FK, Tsai TF, et al. Phase 2 evaluation of parainfluenza type 3 cold passage mutant 45 live attenuated vaccine in healthy children 6-18 months old. J Infect Dis. 2004;189:462-470. (Pubitemid 38210583)
10. Karron RA, Belshe RB, Wright PF, et al. A live human parainfluenza type 3 virus vaccine is attenuated and immunogenic in young infants. Pediatr Infect Dis J. 2003;22:394-405. (Pubitemid 36578739)
11. Madhi SA, Cutland C, Zhu Y, et al. Transmissibility, infectivity and immunogenicity of a live human parainfluenza type 3 virus vaccine (HPIV3cp45) among susceptible infants and toddlers. Vaccine. 2006;24: 2432-2439. (Pubitemid 43290427)
12. Belshe RB, Newman FK, Anderson EL, et al. Evaluation of combined live, attenuated respiratory syncytial virus and parainfluenza 3 virus vaccines in infants and young children. J Infect Dis. 2004;190:2096-2103. (Pubitemid 39636356)
13. Tang RS, MacPhail M, Schickli JH, et al. Parainfluenza virus type 3 expressing the native or soluble fusion (F) Protein of Respiratory Syncytial Virus (RSV) confers protection from RSV infection in African green monkeys. J Virol. 2004;78:11198-11207. (Pubitemid 39299659)
14. Van Cleve W, Amaro-Carambot E, Surman SR, et al. Attenuating mutations in the P/C gene of human parainfluenza virus type 1 (HPIV1) vaccine candidates abrogate the inhibition of both induction and signaling of type I interferon (IFN) by wild-type HPIV1. Virology. 2006;352: 61-73. (Pubitemid 44164412)
15. Newman JT, Riggs JM, Surman SR, et al. Generation of recombinant human parainfluenza virus type 1 vaccine candidates by importation of temperature-sensitive and attenuating mutations from heterologous paramyxoviruses. J Virol. 2004;78:2017-2028. (Pubitemid 38176733)
16. Greer CE, Zhou F, Legg HS, et al. A chimeric alphavirus RNA replicon gene-based vaccine for human parainfluenza virus type 3 induces protective immunity against intranasal virus challenge. Vaccine. 2007;25: 481-489. (Pubitemid 44856090)